Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195403709> ?p ?o ?g. }
- W3195403709 endingPage "1332.e7" @default.
- W3195403709 startingPage "1325" @default.
- W3195403709 abstract "The purpose of this Clinical Practice Update Expert Review is to provide clinicians with guidance on the diagnosis and management of atrophic gastritis, a common preneoplastic condition of the stomach, with a primary focus on atrophic gastritis due to chronic Helicobacter pylori infection-the most common etiology-or due to autoimmunity. To date, clinical guidance for best practices related to the diagnosis and management of atrophic gastritis remains very limited in the United States, which leads to poor recognition of this preneoplastic condition and suboptimal risk stratification. In addition, there is heterogeneity in the definitions of atrophic gastritis, autoimmune gastritis, pernicious anemia, and gastric neoplasia in the literature, which has led to confusion in clinical practice and research. Accordingly, the primary objective of this Clinical Practice Update is to provide clinicians with a framework for the diagnosis and management of atrophic gastritis. By focusing on atrophic gastritis, this Clinical Practice Update is intended to complement the 2020 American Gastroenterological Association Institute guidelines on the management of gastric intestinal metaplasia. These recent guidelines did not specifically discuss the diagnosis and management of atrophic gastritis. Providers should recognize, however, that a diagnosis of intestinal metaplasia on gastric histopathology implies the diagnosis of atrophic gastritis because intestinal metaplasia occurs in underlying atrophic mucosa, although this is often not distinctly noted on histopathologic reports. Nevertheless, atrophic gastritis represents an important stage with distinct histopathologic alterations in the multistep cascade of gastric cancer pathogenesis.The Best Practice Advice statements presented herein were developed from a combination of available evidence from published literature and consensus-based expert opinion. No formal rating of the strength or quality of the evidence was carried out. These statements are meant to provide practical advice to clinicians practicing in the United States. Best Practice Advice Statements BEST PRACTICE ADVICE 1: Atrophic gastritis is defined as the loss of gastric glands, with or without metaplasia, in the setting of chronic inflammation mainly due to Helicobacter pylori infection or autoimmunity. Regardless of the etiology, the diagnosis of atrophic gastritis should be confirmed by histopathology. BEST PRACTICE ADVICE 2: Providers should be aware that the presence of intestinal metaplasia on gastric histology almost invariably implies the diagnosis of atrophic gastritis. There should be a coordinated effort between gastroenterologists and pathologists to improve the consistency of documenting the extent and severity of atrophic gastritis, particularly if marked atrophy is present. BEST PRACTICE ADVICE 3: Providers should recognize typical endoscopic features of atrophic gastritis, which include pale appearance of gastric mucosa, increased visibility of vasculature due to thinning of the gastric mucosa, and loss of gastric folds, and, if with concomitant intestinal metaplasia, light blue crests and white opaque fields. Because these mucosal changes are often subtle, techniques to optimize evaluation of the gastric mucosa should be performed. BEST PRACTICE ADVICE 4: When endoscopic features of atrophic gastritis are present, providers should assess the extent endoscopically. Providers should obtain biopsies from the suspected atrophic/metaplastic areas for histopathological confirmation and risk stratification; at a minimum, biopsies from the body and antrum/incisura should be obtained and placed in separately labeled jars. Targeted biopsies should additionally be obtained from any other mucosal abnormalities. BEST PRACTICE ADVICE 5: In patients with histology compatible with autoimmune gastritis, providers should consider checking antiparietal cell antibodies and anti-intrinsic factor antibodies to assist with the diagnosis. Providers should also evaluate for anemia due to vitamin B-12 and iron deficiencies. BEST PRACTICE ADVICE 6: All individuals with atrophic gastritis should be assessed for H pylori infection. If positive, treatment of H pylori should be administered and successful eradication should be confirmed using nonserological testing modalities. BEST PRACTICE ADVICE 7: The optimal endoscopic surveillance interval for patients with atrophic gastritis is not well-defined and should be decided based on individual risk assessment and shared decision making. A surveillance endoscopy every 3 years should be considered in individuals with advanced atrophic gastritis, defined based on anatomic extent and histologic grade. BEST PRACTICE ADVICE 8: The optimal surveillance interval for individuals with autoimmune gastritis is unclear. Interval endoscopic surveillance should be considered based on individualized assessment and shared decision making. BEST PRACTICE ADVICE 9: Providers should recognize pernicious anemia as a late-stage manifestation of autoimmune gastritis that is characterized by vitamin B-12 deficiency and macrocytic anemia. Patients with a new diagnosis of pernicious anemia who have not had a recent endoscopy should undergo endoscopy with topographical biopsies to confirm corpus-predominant atrophic gastritis for risk stratification and to rule out prevalent gastric neoplasia, including neuroendocrine tumors. BEST PRACTICE ADVICE 10: Individuals with autoimmune gastritis should be screened for type 1 gastric neuroendocrine tumors with upper endoscopy. Small neuroendocrine tumors should be removed endoscopically, followed by surveillance endoscopy every 1-2 years, depending on the burden of neuroendocrine tumors. BEST PRACTICE ADVICE 11: Providers should evaluate for iron and vitamin B-12 deficiencies in patients with atrophic gastritis irrespective of etiology, especially if corpus-predominant. Likewise, in patients with unexplained iron or vitamin B-12 deficiency, atrophic gastritis should be considered in the differential diagnosis and appropriate diagnostic evaluation pursued. BEST PRACTICE ADVICE 12: In patients with autoimmune gastritis, providers should recognize that concomitant autoimmune disorders, particularly autoimmune thyroid disease, are common. Screening for autoimmune thyroid disease should be performed." @default.
- W3195403709 created "2021-08-30" @default.
- W3195403709 creator A5000074569 @default.
- W3195403709 creator A5015862864 @default.
- W3195403709 creator A5038851564 @default.
- W3195403709 creator A5081503066 @default.
- W3195403709 date "2021-10-01" @default.
- W3195403709 modified "2023-10-15" @default.
- W3195403709 title "AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review" @default.
- W3195403709 cites W1496904506 @default.
- W3195403709 cites W1562732190 @default.
- W3195403709 cites W1564275998 @default.
- W3195403709 cites W1580777038 @default.
- W3195403709 cites W1590131333 @default.
- W3195403709 cites W1604400120 @default.
- W3195403709 cites W1944550686 @default.
- W3195403709 cites W1970266944 @default.
- W3195403709 cites W1970620056 @default.
- W3195403709 cites W1970633635 @default.
- W3195403709 cites W1974940069 @default.
- W3195403709 cites W1977811669 @default.
- W3195403709 cites W1982475509 @default.
- W3195403709 cites W1983140303 @default.
- W3195403709 cites W1984531043 @default.
- W3195403709 cites W1985424042 @default.
- W3195403709 cites W1985966185 @default.
- W3195403709 cites W1997447007 @default.
- W3195403709 cites W2003781437 @default.
- W3195403709 cites W2016193783 @default.
- W3195403709 cites W2018664177 @default.
- W3195403709 cites W2028133886 @default.
- W3195403709 cites W2029397046 @default.
- W3195403709 cites W2029418129 @default.
- W3195403709 cites W2030294121 @default.
- W3195403709 cites W2033006867 @default.
- W3195403709 cites W2035589758 @default.
- W3195403709 cites W2038423162 @default.
- W3195403709 cites W2050332872 @default.
- W3195403709 cites W2052670096 @default.
- W3195403709 cites W2054270153 @default.
- W3195403709 cites W2054617296 @default.
- W3195403709 cites W2066650012 @default.
- W3195403709 cites W2072888348 @default.
- W3195403709 cites W2073337549 @default.
- W3195403709 cites W2076952149 @default.
- W3195403709 cites W2083621120 @default.
- W3195403709 cites W2086870354 @default.
- W3195403709 cites W2093255076 @default.
- W3195403709 cites W2103085046 @default.
- W3195403709 cites W2106811398 @default.
- W3195403709 cites W2116466527 @default.
- W3195403709 cites W2116777095 @default.
- W3195403709 cites W2117885857 @default.
- W3195403709 cites W2120261749 @default.
- W3195403709 cites W2132350514 @default.
- W3195403709 cites W2135873874 @default.
- W3195403709 cites W2136803922 @default.
- W3195403709 cites W2140634654 @default.
- W3195403709 cites W2152152769 @default.
- W3195403709 cites W2152524225 @default.
- W3195403709 cites W2158048233 @default.
- W3195403709 cites W2170203253 @default.
- W3195403709 cites W2170276417 @default.
- W3195403709 cites W2183787411 @default.
- W3195403709 cites W2250073450 @default.
- W3195403709 cites W2300642250 @default.
- W3195403709 cites W2328727400 @default.
- W3195403709 cites W2408116241 @default.
- W3195403709 cites W2416388129 @default.
- W3195403709 cites W2416812111 @default.
- W3195403709 cites W2518082296 @default.
- W3195403709 cites W2582922499 @default.
- W3195403709 cites W2586899865 @default.
- W3195403709 cites W2602367326 @default.
- W3195403709 cites W2602893227 @default.
- W3195403709 cites W2606521355 @default.
- W3195403709 cites W2612101735 @default.
- W3195403709 cites W2655018200 @default.
- W3195403709 cites W2756905595 @default.
- W3195403709 cites W2762315257 @default.
- W3195403709 cites W2790102399 @default.
- W3195403709 cites W2808537568 @default.
- W3195403709 cites W2921353582 @default.
- W3195403709 cites W2923714055 @default.
- W3195403709 cites W2948387191 @default.
- W3195403709 cites W2953923712 @default.
- W3195403709 cites W2981032494 @default.
- W3195403709 cites W2992664796 @default.
- W3195403709 cites W2994257410 @default.
- W3195403709 cites W2994498656 @default.
- W3195403709 cites W2999618662 @default.
- W3195403709 cites W3042498934 @default.
- W3195403709 cites W3093856850 @default.
- W3195403709 cites W3101317282 @default.
- W3195403709 cites W3104766291 @default.
- W3195403709 cites W3121039067 @default.
- W3195403709 cites W3121849822 @default.
- W3195403709 cites W3130942211 @default.